IBJNews

Cook wins approval for new stent

Back to TopCommentsE-mailPrintBookmark and Share

Bloomington-based Cook Medical won approval from the U.S. Food and Drug Administration for its drug-coated stent designed to prop open arteries outside the heart and prevent inflammation that might close them again.

The product, called the Zilver PTX Drug-Eluting Stent, already is approved in 50 other markets, including Australia, Japan and Europe. But the United States accounts for roughly 40 percent of the global market in stents for peripheral arteries, so U.S. approval is key for Cook’s revenue from the Zilver product.

Worldwide, peripheral stents had about $2 billion in sales in 2010, according to market research by various firms pulled together by Inspire MD, an Israel-based company developing technologies for coronary and peripheral stents. Industry analysts expect peripheral stents to grow rapidly to about $3.2 billion by the end of next year.

Peripheral artery disease, or PAD, typically occurs in patients’ legs, and is more common in the increasing number of patients suffering from obesity or diabetes. Stents are flexible metal tubes that hold open a section of an artery.

Current treatment options are not ideal. Within a year of diagnosis, as many as 40 percent of U.S. patients end up having an amputation. And according to Cook, 70 percent of patients whose peripheral arteries are propped open through angioplasty see their arteries close again within a year.

Cook’s Zilver stent is coated with the drug paclitaxel—the same as used on many coronary artery stents—which dampens growth of cells in artery walls. The growth can re-close an artery with a stent in it.

In clinical trials, eight of 10 Zilver patients still had their arteries open a year later. Also, half as many Zilver patients needed to come back for a new surgical procedure as did patients receiving a bare metal stent.

“With this approval, treating PAD in the U.S. will begin to undergo the same revolution that drug elution did for treating coronary artery disease,” Dr. Gary Ansel, director of the Center for Critical Limb Care at Riverside Methodist Hospital in Columbus, Ohio, said in a statement released by Cook. “Drug-eluting stents such as Zilver PTX will move quickly, in my opinion, to become the standard of care for PAD patients worldwide.”

The FDA will require Cook to conduct another five-year clinical trial, involving 900 patients, to further monitor safety and efficacy.

While Cook’s is the first drug-coated stent for peripheral arteries to be approved by the FDA, it is likely to see fierce competition.

Minnesota-based Medtronic Inc. has been testing a drug-coated balloon that would prop open arteries, cut down re-closing and yet leave no stent behind.

Also, Illinois-based Abbott Laboratories has been testing its Xpert stent as a treatment for peripheral artery disease.

Still, Rob Lyles, global leader of Cook’s perhperhal intervention division, expressed confidence.

“No other company can match Cook’s commitment to this technology,” he said in a prepared statement, “and by the end of 2013, we expect to have a full suite of drug-eluting peripheral stents in the most commonly used lengths and diameters available to U.S. physicians.”

 

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. I would not vote for Bayh if he did run. I also wouldn't vote for Pence. My guess is that Bayh does not have the stomach to oppose persons on the far left or far right. Also, outside of capitalizing on his time as U. S. Senator (and his wife's time as a board member to several companies) I don't know if he is willing to fight for anything. If people who claim to be in the middle walk away from fights with the right and left wing, what are we left with? Extremes. It's probably best for Bayh if he does not have the stomach for the fight but the result is no middle ground.

  2. JK - I meant that the results don't ring true. I also questioned the 10-year-old study because so much in the "health care system" has changed since the study was made. Moreover, it was hard to get to any overall conclusion or observation with the article. But....don't be defensive given my comments; I still think you do the best job of any journalist in the area shedding light and insight on important health care issues.

  3. Probably a good idea he doesn't run. I for one do not want someone who lives in VIRGINIA to be the governor. He gave it some thought, but he likes Virginia too much. What a name I cannot say on this site! The way these people think and operate amuses me.

  4. Kent definitely has talent and he may even "win" the afternoon drive time competition, but do we really need 3 local sports talk shows? Can't we get just one show with a national presence?!? I loved Doug Gottlieb in that slot and have now switched back to music. How many times can we talk about Hibbert's implosion or Reggie Wayne's knee?? All these guys know national sports, but it always seem to pull right back to Indiana sports (x3).

  5. is only popular in Maroon COunty

ADVERTISEMENT